These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 15569815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apical hypertrophic cardiomyopathy and left ventricular non-compaction: two faces of the same disease.
    Monserrat L, Barriales-Villa R, Hermida-Prieto M.
    Heart; 2008 Oct; 94(10):1253. PubMed ID: 18801786
    [No Abstract] [Full Text] [Related]

  • 3. Pathogenesis of hypertrophic cardiomyopathy. Impact of growth factors on left ventricular anatomy.
    Migliore T, Parrella LS, Caputi A, Silvestri N, Romano R, Pace L, Imbriaco M, Losi MA, Betocchi S.
    Minerva Cardioangiol; 2008 Feb; 56(1):13-20. PubMed ID: 18432164
    [Abstract] [Full Text] [Related]

  • 4. [Apical hypertrophic cardiomyopathy].
    Trémeau G, Aupetit JF, Buttard P, Chapon P, Gayet C, Milon H.
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1283-9. PubMed ID: 8952826
    [Abstract] [Full Text] [Related]

  • 5. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
    Maron MS, Lesser JR, Maron BJ.
    Am J Cardiol; 2010 Jun 15; 105(12):1842-3. PubMed ID: 20538141
    [Abstract] [Full Text] [Related]

  • 6. Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.
    Spirito P, Autore C.
    Eur Heart J; 2007 Aug 15; 28(16):1923-4. PubMed ID: 17623677
    [No Abstract] [Full Text] [Related]

  • 7. Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy.
    Maron BJ, Lindberg J, Haas TS, Kitner C, Lesser JR.
    Am J Cardiol; 2010 Jun 01; 105(11):1643-4. PubMed ID: 20494677
    [No Abstract] [Full Text] [Related]

  • 8. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
    Dumont CA, Monserrat L, Peteiro J, Soler R, Rodriguez E, Bouzas A, Fernández X, Pérez R, Bouzas B, Castro-Beiras A.
    Am J Cardiol; 2007 May 15; 99(10):1454-7. PubMed ID: 17493479
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ.
    Circulation; 2008 Oct 07; 118(15):1541-9. PubMed ID: 18809796
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
    Bauersachs J, Störk S, Kung M, Waller C, Fidler F, Hoyer C, Frantz S, Weidemann F, Ertl G, Angermann CE.
    Eur J Clin Invest; 2007 Nov 07; 37(11):852-9. PubMed ID: 17973781
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you.
    Carasso S, Rakowski H.
    J Am Soc Echocardiogr; 2008 Dec 07; 21(12):1306-8. PubMed ID: 19041573
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
    Popović ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY.
    J Am Soc Echocardiogr; 2008 Dec 07; 21(12):1299-305. PubMed ID: 19041572
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec 07; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.